AzTrials
AzTrials

Prolonged Mechanical VentilationNCT06642714

Standardized Tracheostomy Weaning Protocol for Prolonged Mechanical Ventilation

A study testing Standardized Stepwise Weaning Protocol in people with Prolonged Mechanical Ventilation and Ventilator Weaning, run by Capital Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluated the feasibility and clinical outcomes of a standardized weaning protocol for tracheostomized patients requiring prolonged mechanical ventilation. The protocol was delivered in a specialized weaning unit of a tertiary rehabilitation hospital and combined early noninvasive ventilation, progressive… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Standardized Stepwise Weaning Protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteChina
Study dates
1 Jan 2025to 30 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older;
  • Tracheostomy in place at the time of referral or enrollment;
  • Prolonged mechanical ventilation, defined according to the National Association for Medical Direction of Respiratory Care consensus as the need for invasive mechanical ventilation for more than 6 hours per day for at least 21 consecutive days;
  • Consecutively referred or admitted to the specialized weaning unit between January 1, 2025 and October 31, 2025 for active weaning rehabilitation;
  • Written informed consent provided by the participant or the participant's legally authorized representative.

Who cannot join

  • Referral intended solely for clinical stabilization before discharge to home or nursing care rather than for an active weaning attempt;
  • End-stage disease with life expectancy of less than 3 months;
  • Death or discharge within 14 days after referral;
  • Refusal to provide informed consent.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Beijing Rehabilitation Hospital of Capital Medical University

    Beijing

Other trials in China

About this study

Official title: Early Noninvasive Ventilation and Progressive High-Flow Oxygen Therapy Through a Tracheostomy Tube Weaning Protocol in Tracheostomized Patients With Prolonged Mechanical Ventilation: A Prospective Single-Arm Interventional Study

This study evaluated the feasibility and clinical outcomes of a standardized weaning protocol for tracheostomized patients requiring prolonged mechanical ventilation. The protocol was delivered in a specialized weaning unit of a tertiary rehabilitation hospital and combined early noninvasive ventilation, progressive high-flow oxygen therapy through the tracheostomy tube, spontaneous breathing trials when appropriate, and stepwise reduction of ventilatory support. The main outcome was successful liberation from mechanical ventilation within 60 days.

Read the detailed description

Patients who require prolonged mechanical ventilation after tracheostomy often have respiratory muscle weakness, impaired load-capacity balance, multiple comorbidities, and a high risk of delayed liberation from mechanical ventilation. These patients may have difficulty tolerating abrupt transition to unsupported breathing, and conventional weaning approaches may not be sufficient for all patients.

This study was conducted in a specialized weaning unit of a tertiary rehabilitation hospital. The intervention was a standardized, stepwise weaning protocol for tracheostomized patients with prolonged mechanical ventilation. The protocol included daily assessment of clinical stability and readiness for weaning, gradual reduction of ventilatory support, early use of noninvasive ventilation when appropriate, progressive high-flow oxygen therapy delivered through the tracheostomy tube, spontaneous breathing trials when clinically feasible, airway clearance, rehabilitation, nutritional support, and multidisciplinary reassessment.

The purpose of the protocol was to facilitate safe liberation from mechanical ventilation while minimizing the risk of weaning failure and early reconnection to ventilatory support. Participants were followed for weaning outcomes, reconnection after successful weaning, survival status, and other clinical outcomes according to the study protocol.

Being tested
Standardized Stepwise Weaning Protocol
Keywords
Prolonged mechanical ventilation, Tracheostomy, Ventilator weaning, Noninvasive ventilation, High-flow oxygen therapy, Specialized weaning unit, Rehabilitation hospital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standardized Stepwise Weaning ProtocolOther

    The intervention was a standardized stepwise weaning protocol for tracheostomized patients requiring prolonged mechanical ventilation. Clinical stability and readiness for weaning were assessed before protocol initiation. Ventilator support was gradually reduced according to patient tolerance. When patients met predefined readiness criteria, spontaneous breathing trials were performed under pressure support ventilation. Patients who tolerated spontaneous breathing trials transitioned to progressively longer periods of high-flow oxygen therapy delivered through the tracheostomy tube. Noninvasive ventilation was used when appropriate to support transition from invasive ventilation and facilitate liberation from ventilatory support. Patients were reconnected to the ventilator if signs of respiratory distress or clinical instability occurred. Airway clearance, rehabilitation, nutritional support, and multidisciplinary reassessment were integrated throughout the protocol.

Study groups in NCT06642714
Study groupRoleWhat they receive
Standardized Weaning ProtocolExperimentalParticipants in this single-group study received a standardized stepwise weaning protocol in a specialized weaning unit. The protocol included daily assessment of clinical stability and weaning readiness, gradual reduction of ventilatory support, spontaneous breathing trials when clinically feasible, early noninvasive ventilation when appropriate, progressive high-flow oxygen therapy through the tracheostomy tube, airway clearance, rehabilitation, nutritional support, and multidisciplinary reassessment.
Receives: Other: Standardized Stepwise Weaning Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Participants With Successful Weaning Within 60 Days

    Successful weaning was defined as breathing without invasive mechanical ventilator assistance for at least 5 consecutive days. The outcome was calculated as the percentage of enrolled participants who achieved successful weaning within 60 days after enrollment.

    Measured: From enrollment to 60 days after enrollment

Secondary outcomes (3)
  1. Time From Enrollment to Successful Weaning

    Weaning duration was defined as the number of days from enrollment to the first day on which the participant met the definition of successful weaning.

    Measured: From enrollment to successful weaning, assessed up to 60 days after enrollment

  2. Percentage of Successfully Weaned Participants Reconnected to Invasive Ventilation Within 30 Days

    Reconnection was defined as the need to resume invasive mechanical ventilator assistance within 30 days after successful weaning. This outcome was calculated among participants who achieved successful weaning.

    Measured: From successful weaning to 30 days after successful weaning

  3. All-Cause Mortality at 6 Months

    All-cause mortality was defined as death from any cause within 6 months after enrollment.

    Measured: From enrollment to 6 months after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2024
  2. Study start1 Jan 2025
  3. Primary completion31 Dec 2025
  4. Study completion30 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Prospective, single-group interventional study evaluating a standardized stepwise weaning protocol in tracheostomized patients requiring prolonged mechanical ventilation in a specialized weaning unit.
Masking
None (open label)
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06642714
Sponsor's protocol ID
2025Z-001
Status last verified
May 2026
First submitted
9 Oct 2024
Last updated
28 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zhang C, Zhang R, Ge J, Li Q, Yang B, Zhang B, Wang J, Zhou T, Jiang H. Effectiveness of a standardized weaning protocol in tracheostomized patients with prolonged mechanical ventilation: a prospective single-arm interventional trial. J Intensive Care. 2026 Sep 2;14(1):95. doi: 10.1186/s40560-026-00935-x.

    PubMed 42687196

Questions about this trial

What is this clinical trial studying?

A study testing Standardized Stepwise Weaning Protocol in people with Prolonged Mechanical Ventilation and Ventilator Weaning, run by Capital Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Participants With Successful Weaning Within 60 Days (time frame: From enrollment to 60 days after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06642714, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in